XML 19 R4.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF INCOME (LOSS) - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Income Statement [Abstract]      
Net sales $ 1,074,751 $ 963,875 $ 994,852
Cost of sales 589,418 562,698 562,486
Gross profit 485,333 401,177 432,366
Operating expenses:      
Selling, general and administrative 335,690 297,724 327,274
Research and development 71,247 57,537 65,615
Legal settlement 10,036 18,684  
Impairment charges 4,283 36,504 23,750
Contingent consideration expense (benefit) 3,161 (7,960) (232)
Acquired in-process research and development   250 525
Total operating expenses 424,417 402,739 416,932
Income (loss) from operations 60,916 (1,562) 15,434
Other income (expense):      
Interest income 769 604 (291)
Interest expense (5,261) (9,994) (12,413)
Other expense - net (2,507) (2,279) (537)
Total other expense - net (6,999) (11,669) (13,241)
Income (loss) before income taxes 53,917 (13,231) 2,193
Income tax expense (benefit) 5,463 (3,388) (3,258)
Net income (loss) $ 48,454 $ (9,843) $ 5,451
Earnings (loss) per common share      
Basic (in dollars per share) $ 0.86 $ (0.18) $ 0.10
Diluted (in dollars per share) $ 0.84 $ (0.18) $ 0.10
Weighted average shares outstanding      
Basic (in shares) 56,145 55,434 55,075
Diluted (in shares) 57,359 55,434 56,235